Fibrinogen Concentrate Articles
Orphan status for CSL Behring's RiaSTAP
16 March 2009
FDA approves CSL Behring's RiaSTAP
26 January 2009
CSL submits BLA for fibrinogen products
28 July 2008
EC CPMP OCTOBER MEETING
9 November 1992
Showing 1-4 of 4 articles
- 1
- Is failure to adopt business process management putting the pharma industry at risk?
- Ignyta acquires Actagene Oncology and entry into cancer personalized medicine
- New Zealand declines Alexion's funding application for Solaris
- AstraZeneca's naloxegol meets endpoints; EMA validates Gilead's sofosbuvir MAA
- Sanofi and Regeneron's dupilumab shows 87% reduction in risk of asthma exacerbations
